Revenue almost doubled to $29.3 million from $15.3 million due to contributions from CS Company, a New Zealand cosmetics and fragrance distributor for 60 brands including Marc Jacobs and Calvin Klein. Trilogy acquired it in August for $37 million.
Excluding CS Company, affected by one-off acquisition costs and adjustments, net profit before tax rose 345 per cent to $4.9 million and the half-year revenue rose 58 percent to $24.2 million.
Chief executive Angela Buglass told The Australian: "We are pleased with the first-half performance and the increased momentum we are seeing across the portfolio."
Shareholders will also be smiling after Trilogy’s shares rose 3.8 per cent to a record $2.44 on November 25. In total, stock has climbed 239 percent so far this year, making Trilogy the best performer on the S&P NZX All Capital Index.
One of the happy shareholders will no doubt be Sarah Gibbs, who founded Trilogy (the skincare range) with sister Catherine de Groot before selling the business to candlemakers Ecoya for $20 million in 2010.
Ecoya changed its name to Trilogy International in 2013 as the skincare range dominated sales over the scented candles. When Trilogy reported its annual results in May this year, it marked the first time that the Ecoya side of the business moved into profitability.
While Christmas may already have come for shareholders, the company will be ramping up its campaigns in Christmas with a focus on building brand awareness.
Trilogy expects full-year results to be in line with earlier forecasts for revenue of $75 million to $79 million, and earnings before interest and tax of $12 million to $14 million.